Latest News
PressReleaseJun21_21_web
Upon TFDA issuance of an EUA in Taiwan, an EUA will be issued in Paraguay and Vaxxinity will deliver 1MM doses of its COVID-19 vaccine to Paraguay Paraguay suffers one of the worst COVID-19 outbreaks per capita in the world, with more than 400,000 total cases and 11,000 deaths within the population of 7 million Vaxxinity’s commitment to Paraguay demonstrates one of its core missions to democratize health worldwide, focusing on countries with the greatest need The Vaxxinity UB-612 vaccine is the first Multitope protein/synthetic peptide vaccine to fight the SARS-CoV-2 virus. The UB-612 vaccine elicits broad humoral or
Media Contacts

Have a media inquiry? Looking for more info ?

Contact one of our team members below:

Diane Murphy

Media Relations

[email protected]

Subscribe to Newsletter